Quarterly report pursuant to Section 13 or 15(d)

Note 24 - Segment Information: Schedule of Segment Information (Tables)

v3.19.1
Note 24 - Segment Information: Schedule of Segment Information (Tables)
3 Months Ended
Mar. 31, 2019
Tables/Schedules  
Schedule of Segment Information

 

 

 

Cannabis and

Medical

Marijuana

Segment

 

Facility

Operations

Related

 

Corporate

and

Eliminations

 

Consolidated

Three months ended March 31, 2019

 

 

 

 

 

 

 

 

Net revenue

$

120,089

$

955,906

$

-

$

1,075,995

Operating income (loss)

 

(606,697)

 

171,179

 

(266,726)

 

(856,244)

Interest income

 

20,679

 

3

 

21,898

 

42,580

Interest expense

 

-

 

5,657

 

(1,134)

 

4,523

Property additions

 

-

 

156,891

 

-

 

156,891

Depreciation and amortization

 

-

 

8,020

 

2,932

 

10,952

 

 

 

 

 

 

 

 

 

Three months ended March 31, 2018

 

 

 

 

 

 

 

 

Net revenue

$

160,528

$

855,671

$

-

$

1,016,199

Operating income (loss)

 

76,765

 

26,487

 

(323,323)

 

(220,071)

Interest income

 

23,421

 

-

 

15,646

 

39,067

Interest expense

 

-

 

5,262

 

(1,134)

 

4,128

Property additions

 

-

 

-

 

2,399

 

2,399

Depreciation and amortization

 

-

 

2,592

 

1,708

 

4,300